Christopher Bunka - Jul 29, 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Chris Bunka/
Stock symbol
LEXX
Transactions as of
Jul 29, 2025
Transactions value $
$25,241
Form type
4
Date filed
7/30/2025, 05:12 PM
Previous filing
May 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BUNKA CHRISTOPHER Director SUITE 100, 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA /Chris Bunka/ 2025-07-30 0001103780

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $14.4K +15.6K +6.13% $0.92 270K Jul 29, 2025 Private Holding Company
transaction LEXX common shares Purchase $10.9K +11.9K +4.41% $0.91 282K Jul 30, 2025 Private Holding Company
holding LEXX common shares 374K Jul 29, 2025 Direct
holding LEXX common shares 254K Jul 29, 2025 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 26K Jul 29, 2025 Common Shares 26K $3.00 Direct
holding LEXX Stock Options 49.3K Jul 29, 2025 Common Shares 23.3K $3.00 Direct
holding LEXX Stock Options 64.3K Jul 29, 2025 Common Shares 15K $3.00 Direct
holding LEXX Stock Options 94.3K Jul 29, 2025 Common Shares 30K $2.91 Direct
holding LEXX Stock Options 124K Jul 29, 2025 Common Shares 30K $1.15 Direct
holding LEXX Stock Options 174K Jul 29, 2025 Common Shares 49.5K $2.36 Direct
holding LEXX Stock Options 185K Jul 29, 2025 Common Shares 11K $1.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.